Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It pl... Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -5.1 | -23.6111111111 | 21.6 | 21.6 | 13.82 | 54232 | 16.7024988 | CS |
4 | -3.595 | -17.8900223936 | 20.095 | 25.97 | 13.82 | 61088 | 20.27455898 | CS |
12 | 11.5804 | 235.393121392 | 4.9196 | 28.68 | 4.11 | 603168 | 14.29793025 | CS |
26 | 2.25 | 15.7894736842 | 14.25 | 28.68 | 4.11 | 302258 | 13.56491634 | CS |
52 | -1.5 | -8.33333333333 | 18 | 28.68 | 4.11 | 166294 | 13.78306484 | CS |
156 | -26.75 | -61.8497109827 | 43.25 | 44.5 | 4.11 | 125880 | 22.67535038 | CS |
260 | -408.5 | -96.1176470588 | 425 | 1349.75 | 4.11 | 257672 | 196.2710678 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.